{"id":682,"date":"2016-12-29T11:11:38","date_gmt":"2016-12-29T10:11:38","guid":{"rendered":"http:\/\/iguala3.org\/?p=682"},"modified":"2016-12-29T11:11:38","modified_gmt":"2016-12-29T10:11:38","slug":"farmaco-desarrollado-clinic-protege-cerebro-tras-ictus","status":"publish","type":"post","link":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/","title":{"rendered":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus"},"content":{"rendered":"<div id=\"attachment_683\" style=\"width: 310px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-683\" class=\"wp-image-683 size-medium\" src=\"http:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia-300x169.jpg\" alt=\"fuente-la-vanguardia\" width=\"300\" height=\"169\" srcset=\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia-300x169.jpg 300w, https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia-768x432.jpg 768w, https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia-600x338.jpg 600w, https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg 992w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><p id=\"caption-attachment-683\" class=\"wp-caption-text\"><em>Fuente: La Vanguardia<\/em><\/p><\/div>\n<p>En estos momentos la<b> \u00fanica terapia <\/b>aprobada para tratar el ictus en su fase aguda \u2013 justo despu\u00e9s de que el trombo obstruya una arteria y deje sin riego sangu\u00edneo una parte del cerebro \u2013 es la <b>eliminaci\u00f3n del co\u00e1gulo<\/b>. Ahora, un f\u00e1rmaco desarrollado en el Hospital Cl\u00ednic de Barcelona abre la puerta a una<b> nueva forma de combatir la enfermedad protegiendo el cerebro<\/b>. La sustancia, llamada <b>\u00e1cido \u00farico<\/b>, multiplica por seis las probabilidades de que una parte de los pacientes se recuperen hasta dejar de ser dependientes, seg\u00fan publica esta semana la revista <a href=\"http:\/\/journals.sagepub.com\/doi\/full\/10.1177\/1747493016684354\" data-gtm-element=\"container-child-link\"><i>International Journal of Stroke<\/i> <\/a>.<\/p>\n<p>El f\u00e1rmaco neutraliza los llamados <b>radicales libres<\/b>, que son una de las causas m\u00e1s importantes de da\u00f1o a las neuronas durante el ictus, seg\u00fan \u00c1ngel Chamorro, director de la unidad de ictus del Hospital Cl\u00ednic y autor principal de la investigaci\u00f3n. Cuando un co\u00e1gulo interrumpe el flujo sangu\u00edneo en una arteria del cerebro, la falta de ox\u00edgeno provoca que se generen radicales libres, que son altamente oxidantes y destruyen los componentes de las c\u00e9lulas en una reacci\u00f3n en cadena.<\/p>\n<p>Para m\u00e1s informaci\u00f3n: <strong><a href=\"http:\/\/www.lavanguardia.com\/ciencia\/cuerpo-humano\/20161223\/412837414105\/farmaco-clinic-protege-cerebro-ictus-acido-urico.html\" target=\"_blank\">La Vanguardia<\/a>\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En estos momentos la \u00fanica terapia aprobada para tratar el ictus en su fase aguda \u2013 justo despu\u00e9s de que el trombo obstruya una arteria y deje sin riego sangu\u00edneo una parte del cerebro \u2013 es la eliminaci\u00f3n del co\u00e1gulo. Ahora, un f\u00e1rmaco desarrollado en el Hospital Cl\u00ednic de Barcelona abre la puerta a una [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":683,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[],"class_list":{"0":"post-682","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-noticias","8":"czr-hentry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3<\/title>\n<meta name=\"description\" content=\"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3\" \/>\n<meta property=\"og:description\" content=\"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\" \/>\n<meta property=\"og:site_name\" content=\"Iguala3\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Iguala3\/820765978014722\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-29T10:11:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"992\" \/>\n\t<meta property=\"og:image:height\" content=\"558\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Daniel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@iguala3_\" \/>\n<meta name=\"twitter:site\" content=\"@iguala3_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\"},\"author\":{\"name\":\"Daniel\",\"@id\":\"https:\/\/iguala3.org\/#\/schema\/person\/d33d4dd1218bf367bff9ca9c38661763\"},\"headline\":\"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus\",\"datePublished\":\"2016-12-29T10:11:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\"},\"wordCount\":224,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/iguala3.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\",\"url\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\",\"name\":\"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3\",\"isPartOf\":{\"@id\":\"https:\/\/iguala3.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\",\"datePublished\":\"2016-12-29T10:11:38+00:00\",\"description\":\"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %\",\"breadcrumb\":{\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage\",\"url\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\",\"contentUrl\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg\",\"width\":992,\"height\":558},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/iguala3.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iguala3.org\/#website\",\"url\":\"https:\/\/iguala3.org\/\",\"name\":\"Iguala3\",\"description\":\"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla La Mancha\",\"publisher\":{\"@id\":\"https:\/\/iguala3.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iguala3.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/iguala3.org\/#organization\",\"name\":\"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla-La Mancha\",\"url\":\"https:\/\/iguala3.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/iguala3.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2015\/06\/Logo-color-I3-e1433841997489.jpg\",\"contentUrl\":\"https:\/\/iguala3.org\/wp-content\/uploads\/2015\/06\/Logo-color-I3-e1433841997489.jpg\",\"width\":211,\"height\":87,\"caption\":\"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla-La Mancha\"},\"image\":{\"@id\":\"https:\/\/iguala3.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/pages\/Iguala3\/820765978014722\",\"https:\/\/x.com\/iguala3_\",\"https:\/\/www.instagram.com\/iguala_3\/\",\"https:\/\/www.youtube.com\/channel\/UCPO794h8wGRurN_87MYN99w\/videos\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/iguala3.org\/#\/schema\/person\/d33d4dd1218bf367bff9ca9c38661763\",\"name\":\"Daniel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g\",\"caption\":\"Daniel\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3","description":"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/","og_locale":"es_ES","og_type":"article","og_title":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3","og_description":"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %","og_url":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/","og_site_name":"Iguala3","article_publisher":"https:\/\/www.facebook.com\/pages\/Iguala3\/820765978014722","article_published_time":"2016-12-29T10:11:38+00:00","og_image":[{"width":992,"height":558,"url":"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg","type":"image\/jpeg"}],"author":"Daniel","twitter_card":"summary_large_image","twitter_creator":"@iguala3_","twitter_site":"@iguala3_","twitter_misc":{"Escrito por":"Daniel","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#article","isPartOf":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/"},"author":{"name":"Daniel","@id":"https:\/\/iguala3.org\/#\/schema\/person\/d33d4dd1218bf367bff9ca9c38661763"},"headline":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus","datePublished":"2016-12-29T10:11:38+00:00","mainEntityOfPage":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/"},"wordCount":224,"commentCount":0,"publisher":{"@id":"https:\/\/iguala3.org\/#organization"},"image":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage"},"thumbnailUrl":"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg","articleSection":["Noticias"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/","url":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/","name":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus - Iguala3","isPartOf":{"@id":"https:\/\/iguala3.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage"},"image":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage"},"thumbnailUrl":"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg","datePublished":"2016-12-29T10:11:38+00:00","description":"Asociaci\u00f3n de Familiares, Amigos y Personascon Da\u00f1o Cerebral de Castilla-La Mancha, Iguala3 Iguala3 Da\u00f1o Cerebral Sobrevenido Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus Castilla-La Mancha Iguala3 %","breadcrumb":{"@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#primaryimage","url":"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg","contentUrl":"https:\/\/iguala3.org\/wp-content\/uploads\/2016\/12\/Fuente-la-Vanguardia.jpg","width":992,"height":558},{"@type":"BreadcrumbList","@id":"https:\/\/iguala3.org\/index.php\/2016\/12\/29\/farmaco-desarrollado-clinic-protege-cerebro-tras-ictus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/iguala3.org\/"},{"@type":"ListItem","position":2,"name":"Un f\u00e1rmaco desarrollado en el Cl\u00ednic protege el cerebro tras el ictus"}]},{"@type":"WebSite","@id":"https:\/\/iguala3.org\/#website","url":"https:\/\/iguala3.org\/","name":"Iguala3","description":"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla La Mancha","publisher":{"@id":"https:\/\/iguala3.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iguala3.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/iguala3.org\/#organization","name":"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla-La Mancha","url":"https:\/\/iguala3.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/iguala3.org\/#\/schema\/logo\/image\/","url":"https:\/\/iguala3.org\/wp-content\/uploads\/2015\/06\/Logo-color-I3-e1433841997489.jpg","contentUrl":"https:\/\/iguala3.org\/wp-content\/uploads\/2015\/06\/Logo-color-I3-e1433841997489.jpg","width":211,"height":87,"caption":"Asociaci\u00f3n de Familiares, Amigos y Personas con Da\u00f1o Cerebral de Castilla-La Mancha"},"image":{"@id":"https:\/\/iguala3.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/Iguala3\/820765978014722","https:\/\/x.com\/iguala3_","https:\/\/www.instagram.com\/iguala_3\/","https:\/\/www.youtube.com\/channel\/UCPO794h8wGRurN_87MYN99w\/videos"]},{"@type":"Person","@id":"https:\/\/iguala3.org\/#\/schema\/person\/d33d4dd1218bf367bff9ca9c38661763","name":"Daniel","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bedb13b57e622f0105abf0cd9fc5a6a19b76c3af3a31860544670b433530b2fe?s=96&d=mm&r=g","caption":"Daniel"}}]}},"_links":{"self":[{"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/posts\/682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/comments?post=682"}],"version-history":[{"count":1,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/posts\/682\/revisions"}],"predecessor-version":[{"id":684,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/posts\/682\/revisions\/684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/media\/683"}],"wp:attachment":[{"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/media?parent=682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/categories?post=682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iguala3.org\/index.php\/wp-json\/wp\/v2\/tags?post=682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}